First Arab female astronaut reaches space station
Saudi biomedical scientist Rayyanah Barnawi will carry out breast cancer research while in orbit.
2023-05-22 22:45
Tractor Supply Company Announces Recipients of Inaugural Emerging Artists Program Led by Country Stars Lainey Wilson, Ashley McBryde, Dustin Lynch, Lauren Alaina, and Kat & Alex, Along With Opry Entertainment Group
BRENTWOOD, Tenn.--(BUSINESS WIRE)--May 22, 2023--
2023-05-22 22:29
Germany rejects criticism it watered down language on gas at G7 summit
The German government is rejecting criticism that it pushed to weaken existing commitments for phasing out natural gas at a summit of leaders from the Group of Seven major industrialized democracies
2023-05-22 22:28
Ireland media guide
An overview of the media in Ireland, including links to broadcasters and newspapers.
2023-05-22 22:21
ChatGPT flunks American College of Gastroenterology exams, Feinstein Institutes report
MANHASSET, N.Y.--(BUSINESS WIRE)--May 22, 2023--
2023-05-22 22:17
Auliʻi Cravalho won't reprise titular role of Moana in live-action film, but she will help find new star as executive producer
Auliʻi Cravalho
2023-05-22 21:56
Miley Cyrus explains why she won't be touring any time soon
While she has one of the biggest hits in the music industry in awhile, don't expect Miley Cyrus to go on tour.
2023-05-22 21:51
Duality Featured on Fast Company’s 2023 World Changing Ideas List
SAN MATEO, Calif.--(BUSINESS WIRE)--May 22, 2023--
2023-05-22 21:50
What is fezolinetant? The non-hormonal menopause treatment drug explained
The menopause treatment fezolinetant has been predicted as a “gamechanger” by experts for thousands of women who suffer from hot flushes. The drug, which is the first non-hormonal menopause treatment, was recently approved by America’s FDA. Experts are predicting it could be transformative for women for whom hormone replacement drugs (HRT) are not suitable. The drug was licensed in the US on 12 May and could be approved for use in the UK by the end of the year. According to a British Menopause Society survey, 79 per cent of women aged 45 to 65 experienced hot flushes as a result of their menopause transition, while 10 to 20 per cent describe the hot flushes as “near intolerable”. Here’s everything you need to know about fezolinetant: What is it used to treat? It works to target the menopause symptom of hot flushes. The drug that has been approved by the FDA is made by pharmaceutical company Astella, which advises patients to take one 45-milligram of its VEZOAH (fezolinetant) pill orally, once a day. A large clinical trial of fezolinetant published earlier this year revealed that, after 12 weeks of use, it reduced the frequency of hot flushes by about 60 per cent in women with moderate or severe symptoms, in comparison to a 45 per cent reduction in those who received a placebo. Women involved in the trial also said the drug reduced the severity of hot flushes and improved the quality of their sleep. How does it work? It works by blocking a brain protein called neurokinin-3, which plays a unique role in regulating body temperature in menopausal women. Respondents of the trial have said that the effects of the drug was experienced after taking the first tablet. By comparison, HRT, taken to alleviate menopausal symptoms, replaces the oestrogen that you lose during the menopause transition, either alone or in combination with a progestogen What are the side effects? According to the FDA, the most common side effects are abdominal pain, diarrhoea, insomnia, back pain, hot flush and elevated hepatic transaminases. What have experts said about it? “This is going to be a completely blockbuster drug,” said Prof Waljit Dhillo, an endocrinologist at Imperial College London who led a trial for the drug in 2017 toldThe Guardian. “It’s like a switch. Within a day or two the flushes go away. It’s unbelievable how well these drugs work. It’s going to be completely game changing for a lot of women.” Read More Adenomyosis: 5 things you need to know about the ‘evil twin sister’ of endometriosis ‘Suddenly, I saw Dad again’: The radical technology helping those living with dementia Naga Munchetty reveals womb condition adenomyosis: ‘I live every day on painkillers’
2023-05-22 21:29
DeVry University Partners with Engageli to Further Innovate Its Learning Experience
NAPERVILLE, Ill.--(BUSINESS WIRE)--May 22, 2023--
2023-05-22 21:23
Beyonce laughs off awkward on-stage blunder during sold out concert
Beyonce laughed at her own fumble as she got the words wrong during her sell-out show in Edinburgh on Saturday. In the eyes of her fans, performer and all-round icon Beyonce can do no wrong. But it seems even the superstar herself was caught off guard and had to laugh at her own on-stage error. The funny moment came during a performance of her track HEATED, which comes from her 2022 album Renaissance, which the world tour she is currently on is named after. In the song, the lyric mentions fashion designer Coco Chanel, with the words: “Cuff me, please, cause this ain't fair. Dripped in my pearls like Coco Chanel.” But, during her performance at Edinburgh’s Murrayfield Stadium, Beyonce accidentally pronounced it “Coco Kernel” and immediately laughed at her own mistake while the crowd continued singing the rest of the song before she rejoined them. Sign up to our free Indy100 weekly newsletter The moment was shared by an unofficial Rennaisance tour account with the caption: “Beyoncé has the cutest reaction to messing up the ‘Heated’ verse tonight in Edinburgh.” Fans were happy to see the star having so much fun on her tour, which began on 10 May in Stockholm and is due to end on 27 September in New Orleans. “She’s so real for this,” one fan wrote. Another said: “She seems like she’s having a lot of fun this tour already and I love this for her.” Someone else argued: “Even her flops are legendary.” It comes after some suggested the star “threw shade” at Sweden after clips emerged appearing to show a lacklustre crowd in Stockholm. Have your say in our news democracy. Click the upvote icon at the top of the page to help raise this article through the indy100 rankings.
2023-05-22 21:23
Aspen Power Completes Rooftop Solar Project for New Construction Multifamily Apartments in California
NEW YORK--(BUSINESS WIRE)--May 22, 2023--
2023-05-22 21:21